A Study Comparing the Dulaglutide Pen and the Semaglutide Pen



Status:Recruiting
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:4/5/2019
Start Date:December 20, 2018
End Date:April 15, 2019
Contact:There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Email:clinicaltrials.gov@lilly.com
Phone:1-317-615-4559

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Crossover Study Comparing the Dulaglutide (Trulicity) Pen and the Semaglutide (Ozempic) Pen

In this study participants will try out two different types of drug injection pens
(dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study
drug will be administered.


Inclusion Criteria:

- Diagnosed with type 2 diabetes

- Self-injection naïve to all injectable treatment (for example, diabetes therapies and
other medical conditions)

- Injection naïve to performing all injectable treatment (for example, diabetes
therapies and other medical conditions) to others

Exclusion Criteria:

- Currently diagnosed with gestational diabetes and/or type 1 diabetes

- Cognitive or physical difficulties that could interfere with ability to understand the
training, perform the injection tasks, or complete the study questionnaires as judged
by the investigator

- Is a health care practitioner who is trained in giving injections
We found this trial at
13
sites
L-MARC Research Center
Louisville, Kentucky 40213
Principal Investigator: Harold E. Bays
Phone: 502-214-3990
?
mi
from
Louisville, KY
Click here to add this to my saved trials
PI-Coor Clinical Research, LLC
Annandale, Virginia 22015
Principal Investigator: Connie D Le
Phone: 208-346-8900
?
mi
from
Annandale, VA
Click here to add this to my saved trials
Evidera
Bethesda, Maryland 20814
Principal Investigator: Louis Matza
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
BRCR Medical Center, Inc.
Camp Hill, Pennsylvania 17011
Principal Investigator: Kaushal R Patel
Phone: 208-346-8900
?
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Cedar-Crosse Research Center
Chicago, Illinois 60607
Principal Investigator: Danny H Sugimoto
Phone: 312-431-6780
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Lillestol Research LLC
Fargo, North Dakota 58103
Principal Investigator: Michael Lillestol
Phone: 701-232-7705
?
mi
from
Fargo, ND
Click here to add this to my saved trials
Valley Research
Fresno, California 93720
Principal Investigator: Paul C Norwood
Phone: 559-261-0992
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Juno Research
Houston, Texas 77074
Principal Investigator: Rocio A Harbison
Phone: 713-779-5494
?
mi
from
Houston, TX
Click here to add this to my saved trials
Long Beach Center for Clinical Research
Long Beach, California 90807
Principal Investigator: Deanna G Cheung
Phone: 562-595-9366
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
Manassas Clinical Research Center
Manassas, Virginia 20110
Principal Investigator: Nabil Andrawis
Phone: 703-330-1122
?
mi
from
Manassas, VA
Click here to add this to my saved trials
Palm Harbor Medical Associates
Palm Harbor, Florida 34684
Principal Investigator: Aron Schlau
?
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Carolina Research Center, Inc.
Shelby, North Carolina 28150
Principal Investigator: Stephen W Jones
Phone: 705-787-5228
?
mi
from
Shelby, NC
Click here to add this to my saved trials
Georgia Clinical Research, LLC
Snellville, Georgia 30078
Principal Investigator: John D Lentz, III
Phone: 678-822-5581
?
mi
from
Snellville, GA
Click here to add this to my saved trials